Management of De Novo Mycobacterial Infection After Lung Transplantation Without Rifampicin: Case Series of a Single Institution

Keyphrases

• Lung Transplantation 100%
• Rifampicin 100%
• Mycobacterial Infection 100%
• Single Institution 100%
• Mycobacterium Tuberculosis (M. tb) 42%
• Native Lung 42%
• Nontuberculous Mycobacteriosis 42%
• Immunosuppression 28%
• Forced Expiratory Volume in 1 Second (FEV1) 28%
• Ethambutol 28%
• Acute Rejection 14%
• Cyclosporine 14%
• Clinical Features 14%
• Mycophenolate Mofetil 14%
• Tacrolimus 14%
• Calcineurin Inhibitors 14%
• Chronic Obstructive Pulmonary Disease 14%
• Drug Use 14%
• Blood Concentration 14%
• Trough Level 14%
• Chronic Obstructive Pulmonary Disease Patient 14%
• Levofloxacin 14%
• Organ Transplant Recipients 14%
• Pyrazinamide 14%
• Tuberculosis Infection 14%
• Clarithromycin 14%
• Mycobacterium 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Rifampicin 100%
• Tuberculosis 50%
• Mycobacteriosis 37%
• Chronic Obstructive Lung Disease 25%
• Ethambutol 25%
• Ciclosporin 12%
• Immunosuppressive Agent 12%
• Clinical Feature 12%
• Calcineurin Inhibitor 12%
• Tacrolimus 12%
• Trough Level 12%
• Levofloxacin 12%
• Pyrazinamide 12%
• Isoniazid 12%
• Clarithromycin 12%
• Acute Graft Rejection 12%
• Mycobacteria 12%
• Mycophenolate Mofetil 12%
• Steroid 12%

Immunology and Microbiology

• Infectious Disease 100%
• Lung Transplantation 100%
• Infection 100%
• Lung 33%
• Immunosuppression 22%
• Forced Expiratory Volume 22%
• Blood Level 11%
• Ciclosporin 11%
• Immunosuppressant 11%
• Tacrolimus 11%
• Acute Graft Rejection 11%
• Mycobacteria 11%
• Mycophenolate Mofetil 11%
• Steroid 11%